Author:
Conner James M.,Tuszynski Mark H.
Reference110 articles.
1. Diaz, B. R. and Yamazaki, R. S. (1998) Advances and challenges in the prevention of Alzheimer’s disease. Pharmaceut. Res.
15, 386–398.
2. Terry, R. D., Masliah, E., and Hansen, L. A. (1994) Structural basis of the cognitive alterations in Alzheimer’s disease, Alzheimer’s Disease (Terry, R. D., Katzman, R., and Bick, K. L., eds.), Raven Press, New York, pp. 179–196.
3. Cikson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies, P., Yen, S. H., and Aronson, M. K. (1992). Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging
13, 179–189.
4. Katzman, R., Terry, R., Deteresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., and Peck, A. (1988) Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol.
23, 138–144.
5. Terry, R. D., Hansen, L. A., Deteresa, R., Davies, P., Tobias, H., and Katzman, R. (1987) Senile dementia of the Alzheimer’s type without neocortical neurofibrillary tangle. J. Neuropathol. Exp. Neurol.
46, 262–268.